J7320 HCPCS code: Hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg
J7320 is the HCPCS Level II code for hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg. In 2024 Medicare paid an average of $4.23 per service for J7320 across 3,895,844 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 50 per day on outpatient hospital claims. Medicare volume fell 39% from 2022 to 2024 (6,424,372 to 3,895,844 services). In 2024, about 1,114 clinicians billed Medicare for J7320 for 20,472 beneficiaries; Illinois, New York, California accounted for 39% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2017-01-01 |
| Last action effective | 2018-01-01 |
Who bills J7320 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 1,114 |
| Medicare beneficiaries | 20,472 |
| States with claims | 35 |
| Share of services in top 3 states (Illinois, New York, California) | 39% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J7320, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 6,424,372 | 40,088 | $14.84 | $11.80 |
| 2023 | 4,596,422 | 25,366 | $7.06 | $5.58 |
| 2024 | 3,895,844 | 20,472 | $5.37 | $4.23 |
States with the most J7320 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Illinois | 791,350 | $4.27 |
| New York | 395,668 | $4.22 |
| California | 339,985 | $4.22 |
| Texas | 319,498 | $4.21 |
| New Jersey | 319,378 | $4.23 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 50 | Prescribing Information |
| practitioner claims | 50 | Prescribing Information |
Medicare policy articles for this code
- A52420: Billing and Coding: Hyaluronans Intra-articular Injections of (Wellpoint Federal (MAC - Part A, MAC - Part B))
- A56157: Billing and Coding: Intraarticular Knee Injections of Hyaluronan (WPS Insurance Corporation (MAC - Part A, MAC - Part B))
- A59030: Billing and Coding: Hyaluronic Acid Injections for Knee Osteoarthritis (Palmetto GBA (MAC - Part A, MAC - Part B))
Covered diagnoses (17 ICD-10-CM codes)
The diagnoses most often listed as covered in the policy articles above:
| ICD-10-CM | Diagnosis | Articles listing it |
|---|---|---|
| M17.0 | Bilateral primary osteoarthritis of knee | 3 |
| M17.11 | Unilateral primary osteoarthritis, right knee | 3 |
| M17.12 | Unilateral primary osteoarthritis, left knee | 3 |
| M17.2 | Bilateral post-traumatic osteoarthritis of knee | 3 |
| M17.31 | Unilateral post-traumatic osteoarthritis, right knee | 3 |
| M17.32 | Unilateral post-traumatic osteoarthritis, left knee | 3 |
| M17.4 | Other bilateral secondary osteoarthritis of knee | 3 |
| M17.5 | Other unilateral secondary osteoarthritis of knee | 3 |
| M17.9 | Osteoarthritis of knee, unspecified | 1 |
| M19.011 | Primary osteoarthritis, right shoulder | 1 |
Showing 10 of 17. The full list, non-covered diagnoses and CSV export are in Caduvo.
What changed for J7320
- 2017-01-01: J7320 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J7320?
J7320 is the HCPCS Level II code for hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg. Short descriptor: "Genvisc 850, inj, 1mg".
How much does Medicare pay for J7320?
In 2024, the average Medicare payment was $4.23 per service (average allowed $5.37).
Does Medicare cover J7320?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
Which diagnoses support coverage for J7320?
Medicare policy articles that cite J7320 list 17 covered ICD-10-CM diagnosis codes across 3 articles. The most cited include M17.0 (Bilateral primary osteoarthritis of knee), M17.11 (Unilateral primary osteoarthritis, right knee), M17.12 (Unilateral primary osteoarthritis, left knee). A listed diagnosis is necessary but not sufficient; the policy's other criteria still apply.
How many units of J7320 can be billed per day?
50 on outpatient hospital claims; 50 on practitioner claims (NCCI medically unlikely edits).
Related J73 codes
- J7300 — Intrauterine copper contraceptive (paragard)
- J7301 — Levonorgestrel-releasing intrauterine contraceptive system (skyla), 13.5 mg
- J7302 — Levonorgestrel-releasing intrauterine contraceptive system, 52 mg
- J7303 — Contraceptive supply, hormone containing vaginal ring, each
- J7304 — Contraceptive supply, hormone containing patch, each
- J7306 — Levonorgestrel (contraceptive) implant system, including implants and supplies
- J7307 — Etonogestrel (contraceptive) implant system, including implant and supplies
- J7308 — Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg)
- J7309 — Methyl aminolevulinate (mal) for topical administration, 16.8%, 1 gram
- J7310 — Ganciclovir, 4.5 mg, long-acting implant
- J7311 — Injection, fluocinolone acetonide, intravitreal implant (retisert), 0.01 mg
- J7312 — Injection, dexamethasone, intravitreal implant, 0.1 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J7320
- Watch J7320 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J7320
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.